Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: Possible physiological and therapeutic implications

Fundamental and Clinical Pharmacology

Volumn 10, Issue 1, 1996, Pages 1-15

  Pairet, M ^a   Engelhardt, G ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Constitutive COX; Inducible COX

Indexed keywords

4 (3,5 DI TERT BUTYL 4 HYDROXYPHENYL) 2 METHYL 1,2 OXAZIN 3 ONE; 5 (4 FLUOROPHENYL) 1 [(4 METHYLSULFONYL)PHENYL] 3 TRIFLUOROMETHYLPYRAZOLE; 5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE; 6 (2,4 DIFLUOROPHENYLTHIO) 5 METHANESULFONAMIDO 1 INDANONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DICLOFENAC; FLOSULIDE; IBUPROFEN; IGURATIMOD; INDOMETACIN; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN SYNTHASE;

ANIMAL CELL; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; SIDE EFFECT;

EID: 0029983724     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1996.tb00144.x     Document Type: Review

References (165)

1. Akarasereenont P, Mitchell JA, Bakhle YS, Thiemermann C, Vane JR. Comparison of the induction of cyclooxygenase and nitric oxide synthase by endotoxin in endothelial cells and macrophages. Eur J Pharmacol 1995a;273:121-8
2. Akarasereenont P, Bakhle YS, Thiemermann C, Vane JR. Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide. Br J Pharmacol 1995b;115:401-8
3. Albert TJ, Su HC, Zimmerman PD, Iams JD, Kniss DA. Interleukin-1( regulates the inducible cyclooxygenase in amnion-derived WISH cells. Prostaglandins 1994;48: 401-15
4. 2 and cyclooxygenase-2. Eur J Biochem 1994;226:125-31
5. Appleby SB, Ristimäki A, Neilson K, Narko K, Hla T. Structure of the human cyclo-oxygenase-2 gene, Biochem J 1994;302:723-7
6. Arias-Negrette S, Keller K, Chadee K. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem Biophys Res Commun 1995;208:582-9
7. Bannwarth B, Demotes-Mainard F, Schaeverbeke T, Labat L, Dehais J. Central analgesic effects of aspirin-like drugs. Fund Clin Pharmacol 1995;9:1-7
8. Battistini B, Botting R, Bakhle YS. COX-1 and COX-2: toward the development of more selective NSAIDs. DN&P 1994;7:501-12
9. Bazan NG, Fletcher BS, Herschman HR, Mukherjee PK. Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. Proc Natl Acad Sci USA 1994;91:5252-6
10. Bjarnason I, Hayllar J, Parker J, Schupp J, Macpherson A. A randomised, double blind, crossover comparative endoscopy study on gastroduodenal tolerability of flosulide and naproxen [abstract]. Gastroenterology 1994;106(suppl 4): A53
11. Bonvalet JP, Pradelles P, Farman N. Segmental synthesis and actions of prostaglandins along the nephron. Am J Physiol 1987;253:F377-87
12. Boyce S, Chan CC, Gordon R et al. L-745,337: a selective inhibitor of cyclooxygenase-2 elicitis antinociception but not gastric ulceration in rats. Neuropharmacology 1994; 33:1609-11
13. Breder CD, Smith WL, Raz A, Masferrer JL, Seibert K, Needleman P, Saper CB. The distribution and characterization of cyclooxygenase-like immunoreactivity in the ovine brain. J Comp Neurol 1992;322:543-67
14. Breder CD, DeWitt D, Kraig RP. Characterization of inducible cyclooxygenase in rat brain. J Comp Neurol 1995; 355:196-315
15. Capdevila JH, Morrow JD, Belosludtsev YY, Beauchamp D, DuBois RN, Falck JR. The catalytic outcomes of the constitutive and the mitogen inducible isoforms of prostaglandin H2 synthase are markedly affected by glutathione and glutathione peroxidase(s). Biochemistry 1995;34:3325-37
16. Carmichael J, Shankel SW. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med 1985;78:992-1000
17. Cavanaugh PF Jr, McDonald JS, Pavelic L, Limardi RJ, Gluckman JL, Pavelic ZP. Immunohistochemical localization of prostaglandin H synthase isoenzyme proteins in the gingival tissue of patients with periodontitis. Immunopharmacology 1995;3:109-19
18. Chan CC, Gordon R, Brideau C et al. In vivo pharmacology of L-745,337: a novel non-steroidal antiinflammatory agent (NSAID) with an ulcerogenic sparing effect in rat and monkey stomach [abstract]. Can J Physiol Pharmacol 1994;72(suppl 1):266
19. Chanmugam P, Feng L, Liou S et al. Radicicol, a protein tyrosine kinase inhibitor, suppresses the expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide and in experimental glomerulonephritis. J Biol Chem 1995;270:5418-26
20. Chen Y, Marsh T, Zhang JS, Graham SH. Expression of cyclooxygenase 2 in rat brain following kainate treatment. NeuroReport 1995;6:245-8
21. Churchill L, Graham A, Farina P, Grob P. Inhibition of human cyclooxygenase-2 (COX-2) by meloxicam [abstract]. Rheumatology in Europe 1995;24(suppl 3):D205
22. Copeland RA, Williams JM, Giannaras J et al. Mechanism of selective inhibition of the inducible form of prostaglandin G/H synthase. Proc Natl Acad Sci USA 1994;91: 11202-6
23. Corbett JA, Kwon G, Turk J, McDaniel ML. IL-1β induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. Biochemistry 1993;32:13767-70
24. Créminon C, Habib A, Maclouf J, Pradelles P, Grassi J, Frobert Y. Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays. Biochim Biophys Acta 1995;1254:341-8
25. Crofford LJ, Wilder RL, Ristimäki AP, Sano H, Remmers EF, Epps HR, Hla T. Cyclooxygenase-1 and-2 expression in rheumatoid synovial tissues. J Clin Invest 1994;93: 1095-101
26. CSM update. Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions-2. Br Med J 1986;292:1190-1
27. De Brum-Fernandes AJ, Laporte S, Heroux M, Lora M, Patry C, Menard H, Dumais R, Leduc R. Expression of prostaglandin endoperoxide synthase-1 and prostaglandin endoperoxide synthase-2 in human osteoblasts. Biochem Biophys Res Commun 1994;198:955-60
28. DeWitt DL, Smith WL. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence. Proc Natl Acad Sci USA 1988;85:1412-6
29. DeWitt DL, El-Harth A, Kraemer SA, Andrews MJ, Yao EF, Armstrong RL, Smith, WL. The aspirin and heme binding sites of ovine and murine prostaglandin endoperoxide synthases. J Biol Chem 1990;265:5192-8
30. Distel M, Mueller C, Blumkhi E. Global analysis of safety of a new NSAID, meloxicam [abstract]. Rheumatology in Europe 1995;24 Suppl 3: E259
31. Dubois R, Tsujii M, Bishop P, Awad JA, Makita K, Lanahan A. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am J Physiol 1994;266:G822-G827
32. Eberhardt CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois R. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and carcinomas. Gastroenterology 1994;107:1183-8
33. Engelhardt G. Meloxicam, a potent inhibitor of COX-2 [abstract]. In: Proceedings of the 9th International Conference on Prostaglandins and Related Compounds; 1994 June 6-10;Florence. Milan: Giovanni Lorenzini Medical Foundation, 1994
34. Engelhardt G, Homma D, Schlegel K, Utzmann R, Schnitzler C. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastroinestinal tolerance. Inflammation Res 1995a;in press
35. Engelhardt G, Homma D, Schnitzler C. Meloxicam: a potent inhibitor of adjuvant arthritis in the Lewis rat. Inflammation Res 1995b;in press
36. Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang, D. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys 1993;307:361-88
37. Fletcher BS, Kujubu DA, Perrin DM, Herschman HR. Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10-encoded protein is a functional prostaglandin G/H synthase. J Biol Chem 1992;267:4338-44
38. Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990;265:16737-140
39. Funk CD, Funk LB, Kennedy ME, Pong AS, Fitzgerald GA. Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression and gene chromosomal assignment. FASEB J 1991;5:2304-12
40. Futaki N, Arai I, Hamasaka Y, Takahashi S, Higuchi S, Otomo S. Selective inhibition of NS-398 on prostanoid production in inflamed tissue in rat carrageenan-air-pouch inflammation. J Pharm Pharmacol 1992;45:735-55
41. Futaki N, Yoshikawa K, Hamasaka Y et al. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmac 1993;24:105-10
42. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994;47:55-9
43. Gans KR, Gabraight W, Roman RJ, Haber SB, Kerr JS, Schmidt WK, Smith C, Hewes WE, Ackerman NR. Anti-inflammatory and safety profile of DuP 6976, a novel orally effective prostglandin synthesis inhibitor. J Pharmacol Exp Ther 1990;254:180-7
44. Garcia Rodriguez LA, Jick H. Risks of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:769-72
45. Gierse JK, Hauser SD, Crecly DP, Koboldt C, Rangwala SH, lsakson PC, Seibert K. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. Biochem J 1995;305:479-84
46. Glaser K, Sung ML, O'Neill K et al. Etodolac selectively inhibits human prostaglandin G/H synthase-2 (PGHS-2) versus human PGHS-1. Eur J Pharmacol 1995;281:107-11
47. Goppelt-Struebe M. Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression. Prostaglandins Leukotrienes and essential fatty acids 1995;52: 213-22
48. Greenberg ER, Hamilton SR, Freeman DHJr, Mandel JS, Haile R. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. J Natl Cancer Inst 1993;85:912-6
49. Grossman CJ, Wiseman J, Lucas FS, Trevethick MA, Birch PJ. Inhibition of constitutive and inducible cyclooxygenase activity in human platelets and mononuclear cells by NSAIDs and Cox 2 inhibitors. Inflamm Res 1995;44: 253-7
50. Habib A, Créminon C, Frobert Y, Grassi J, Pradelles P, Maclouf J. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem 1993;268:23448-54
51. Harada Y, Hatanaka K, Saito M et al. Cyclooxygenase-2 in the rat carrageenin-induced pleurisy [abstract]. Jpn J Pharmacol 1995;67(suppl 1):S43-4
52. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 1994;94:2504-10
53. 2. FASEB J 1991;17:2575-81
54. Hempel SL, Monick MM, Hunninghake GW. Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J Clin Invest 1994;93:391-6
55. Herschman HR. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer and Metastasis Reviews 1994;13:241-56
56. Hla T, Neilson, K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci USA 1992;89:7384-8
57. Hla T, Ristimäki A, Appleby S, Barriocanal JG. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann NY Acad Sci 1993;696:197-204
58. Hoff T, DeWitt D, Kaever V, Resch K, Goppelt-Struebe M. Differentiation-associated expression of prostaglandin G/H synthase in monocytic cells. Fed European Biochem Soc 1993;320:38-42
59. Horiguchi S, Ueno R, Hyodo M, Hayaishi O. Alteration in nociception after intracisternal administration of prostaglandin D2, E2 or F2( to conscious mice. Eur J Pharmacol 1986;122:173-9
60. Hudson N, Balsitis M, Filipowicz, Hawkey CJ. Effect of Helicobacter pylori colonization on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. Gut 1993;34:748-51
61. Hughes AK, Padilla E, Kutchera WA, Michael JR, Kohan DE. Endothelin-1 induction of cyclooxygenase-2 expression in rat mesangial cells. Kidney International 1995;47:53-61
62. Iseki S. Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach. Histochem J 1995;27:323-8
63. 2 production from early first trimester human decidual cells is inhibited by dexamethasone and progesterone. Prostaglandins 1995;49:15-26
64. 2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem Biophys Res Commun 1993; 197:1465-74
65. Jones DA, Carlton DP, McIntyre TM, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993;268:9049-54
66. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, Jothy S. Expression of Prostaglandin G/H synthase-1 and-2 protein in human colon cancer. Cancer Research 1995;55: 2556-9
67. Kawahito Y, Sano H, Mukai S, Asai K, Kimura S, Yamamura Y, Kato H, Hla T, Kondo M. Detection of cyclooxygenase-1 and-2-proteins and mRNA in gastric ulcer [Abstract]. Pathophysiology 1994;1:288
68. Kennedy BP, Chan CC, Culp SA, Cromlish WA. Cloning and expression of rat prostaglandin endoperoxide synthase (cyclooxygenase)-2 cDNA. Biochem Biophys Res Commun 1993;197:494-500
69. Klein T, N,sing RM, Pfeilschifter J, Ullrich V. Selective inhibition of cyclooxygenase 2. Biochem Pharmacol 1994;48: 1605-10
70. Knott I, Dieu M, Burton M, Houbion A, Remacle J, Raes M. Induction of cyclooxygenase by interleukin 1: comparative study between human synovial cells and chondrocytes. J Rheumatol 1994;21:462-6
71. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991;266:12866-72
72. Kujubu DA, Herrschman HR. Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase /cyclooxygenase gene. J Biol Chem 1992;267:7991-4
73. Laneuville O, Breuer DK, Dewitt DL, Hla T, Funk CD, Smith WD. Differential inhibition of human prostaglandin endoperoxide H synthases-1 and-2 by nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1994;271:927-34
74. Langman MJ, Weil J, Wainwright P, Lawson DH, Rawling MD, Logan RFA, Murphy M, Vessey MP, Colin-Jones DG. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994; 343:1075-8
75. Lee SH, Soyoola E, Chanmugam P, Hart S, Sun W, Zhong H, Liou S, Simmons D, Hwang D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J Biol Chem 1992;267: 25934-8
76. Lichtenstein DR, Syngal S, Wolfe M. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. Arthritis Rheum 1995;1:5-18
77. Logan RF, Little J, Hawtin PG, Hardcastle JD. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: case-control study of subjects participating in the Nottingham faecal occult blood screening programm. BMJ 1993;307:285-9
78. Loll PL, Garavito RM. The isoforms of cyclooxygenase: structure and function. Curr Opin Invest Drugs 1994;3:1171-80
79. Lyons-Giordano B, Pratta MA, Galbraith W, Davis GL, Arner EC. Interleukin-1 differentially modulates chondrocyte expression of cyclooxygenase-2 and phospholipase A2. Experimental Cell Res 1993;206:58-62
80. Masferrer JL, Zweifel BS, Seibert K, Needleman P. Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 1990;86:1375-9
81. Masferrer JL, Seibert K, Zweifel BS, Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci USA 1992;89:3917-21
82. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leah KM, Smith WG, Isakson PC, Seibert K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci USA 1994a;91: 3228-32
83. Masferrer JL, Reddy ST, Zweifel BS, Seibert K, Needleman P, Gilbert RS, Herschman HR. In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. J Pharmacol Exp Ther 1994b;270: 1340-4
84. Matsuda K, Sakamoto C, Mizuno H, Noguchi H, Matozaki T, Wada K, Uchida T, Konda Y, Kasuga M. Gene expression of cyclooxygenase and EGF-like growth factors in different stages of the mouse gastric ulcer [Abstract]. Gastroenterology 1994;106:A132
85. Meade EA, Smith WL, DeWitt DL. Expression of the murine prostaglandin (PGH) synthase-2 isozymes in cos-1 cells. J Lipid Mediators 1993a;6:119-29
86. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other Non-Steroidal Anti-inflammatory Drugs. J Biol Chem 1993b;268:6610-4
87. Merlie JP, Fagan D, Mudd J, Needleman P. Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase). J Biol Chem 1988;263:3550-3
88. Mertz PM, DeWitt DL, Stetler-Stevenson WG, Wahl LM. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. J Biol Chem 1994;269:21322-9
89. Mitchell JA, Belvisi mg, Akarasereenont PA, Robbins RA, Kwon OJ, Croxtall J, Barnes P, Vane JR. Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol 1994a;113:1008-14
90. Mitchell JA, Akarasereenont, P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1994b;90:11693-7
91. Monta I, Schindler M, Regier MK, Otto JC, Hori T, DeWitt DL, Smith WL. Different intracellular locations for prostaglandin endoperoxide H synthase-1 and-2. J Biol Chem 1995;18:10902-8
92. Murray MD, Brater DC. Renal toxicity of nonsteroidal antiinflammatory drugs. Annu Rev Pharmacol Tox 1993;32: 435-65
93. O'Banion MK, Sadowski HB, Winn V, Young DA. A serum-and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein. J Biol Chem 1991; 266:23261-7
94. O'Banion MK, Winn VD, Young DA. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc Natl Acad Sci USA 1992;89: 4888-92
95. O'Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett 1993;330:156-60
96. O'Neill GP, Mancini JA, Kargman S, Yergey J, Kwan MY, Falgueyret JP, Abramovitz M, Kennedy BP, Quellet M, Cromlish W, Culp S, Evans JF, Ford-Hutchinson AW, Vickers PJ. Overexpression of human prostaglandin G/H synthase-1 and-2 by recombinant vaccinia virus: inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Molec Pharmacol 1994;45:245-54
97. O'Sullivan mg, Chilton FH, Huggins EMJr, McCall CP. Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase. J Biol Chem 1992;267: 14547-50
98. Otto JC, DeWitt DL, Smith WL. N-Glycosylation of prostaglandin endoperoxide synthases-1 and-2 and their orientations in the endoplasmic reticulum. J Biol Med 1993; 268:18234-42
99. Ouellet M, Percival MD. Effect of inhibitor time-dependency and selectivity towards cyclooxygenase isoforms. Biochem J 1995;306:247-51
100. Pairet M, Engelhardt G. Relationship between COX-2 selectivity in vitro and improved safety profile in vivo for NSAIDs [abstract]. Pharmacological Res 1995a;31 (suppl): p131
101. Pairet M, Engelhardt G. The preferential inhibition of COX-2 by meloxicam is highly dependent of the structure of the drug [abstract]. Rheumatology in Europe 1995b;24 (suppl 3): D204
102. Pairet, Engelhardt G, Lidbury P, Vane JR. Meloxicam: cyclooxygenase selectivity, antiinflammatory activity and gastric and renal safety [abstract]. Second World Congress on Inflammation, Brighton, UK, September 17th-22nd 1995
103. Patoia L, Santucci L, Furno P, Dionisi MS, Dell'Orso S, Romagnoli M, Marini mg: Comparison of gastrointestinal tolerability of meloxicam, piroxicam and placebo by fecal blood loss, endoscopy and symptom evaluation [abstract]. Rheumatology Eur 1995;24 (suppl 3): E258
104. Patrignani P, Panara MR, Greco A et al. Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 1994;271:1705-10
105. Patrignani P, Panara M, Greco A et al. The antiinflammatory compounds L-745,337 and NS-398 are selective inhibitors of prostaglandin endoperoxide synthase-2 in human blood monocytes [abstract]. Pharmacological Res 1995;31 (suppl): 311
106. Picot D, Loll PJ, Garavito RM. The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature 1994;367:243-9
107. Ping XW, Warden C, Fletcher BS, Kujubu DA, Herschman HR, Lusis AL. Chromosomal organization of the inducible and constitutive prostaglandin synthase/cyclooxygenase genes in mouse. Oncogene 1993;6:995-9
108. Pomerantz KB, Summers B, Hajjar DP. Eicosanoid metabolism in cholesterol-enriched arterial smooth muscle cells. Evidence for reduced posttranscriptional processing of cyclooxygenase I and reduced cyclooxygenase II gene expression. Biochemistry 1993;32:13624-35
109. Pritchard KAJr, O'Banion MK, Miano J, Vlasic N, Bhatia UG, Young DA, Stemerman MB. Induction of cyclooxygenase-2 in rat vascular smooth muscle cells in vitro and in vivo. J Biol Chem 1994;269:8504-9
110. Rainsford KD, Quadir M. Gastrointestinal damage and bleeding from non-steroidal anti-inflammatory drugs. I. clinical and epidemiological aspects. Immunopharmacology 1995;3: 169-90
111. Raz A, Wyche A, Siegel N, Needleman P. Regulation of fibroblast cyclooxygenase synthesis by interleukin-1. J Biol Chem 1988;263:3022-5
112. Raz A, Wyche A, Needleman P. Temporal and pharmacological division of fibroblast cyclooxygenase expression into transcriptional and translation phases. Proc Natl Acad Sci USA 1989;86:1657-61
113. Reddy ST, Herschman HR. Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase in murine fibroblasts and macrophages. J Biol Chem 1994;269:15473-80
114. Reitz DB, Li JL, Norton MB et al. Selective cyclooxygenase inhibitors: novel 1,2-diarylcyclopentenes are potent and orally active COX-2 inhibitors. J Med Chem 1994;37: 3878-81
115. Riese J, Hoff T, Nordhoff A, DeWitt DL, Resch K, Kaever V. Transient expression of prostaglandin endoperoxide synthase-2 during mouse macrophage activation. J Leukoc Biol 1994;55:476-82
116. Rimarachin JA, Jacobson JA, Szabo P, Maclouf J, Creminon C, Weksler BB. Regulation of cyclooxygenase-2 expression in aortic smooth muscle cells. Arteriosocler Thromb 1994;14:1021-31
117. Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979;77:761-7
118. Rosen GD, Birkenmeier TM, Raz A, Holtzman MJ. Identification of cyclooxygenase-related gene and its potential role in prostaglandin formation. Biochem Biophys Res Commun 1989;164:1358-65
119. Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro SA. A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 1991;83:355-8
120. 2 synthesis in rabbit synoviocytes. Arthritis Rheum 1987;30:266-73
121. Rzymkiewicz D, Leingang K, Baird N, Morrison AR. Regulation of prostaglandin endoperoxide synthase gene expression in rat mesangial cells by interleukin-1β. Am J Physiol 1994;266: F39-F45
122. Salvemini D, Settle SL, Masferrer JL, Seibert K, Currie mg, Needleman P. Regulation of prostaglandin production by nitric oxide, an in vivo analysis. Br J Pharmacol 1995;114:1171-8
123. Sano H, Hla T, Maier JAM et al. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 1992;89:97-108
124. Seibert K, Zhang Y, Leahy K et al. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci USA 1994a;91: 12013-7
125. Seibert K, Gierse J, Zhang Y et al. Expression and selective inhibition of constitutive and inducible forms of cyclooxygenase [abstract]. In: Proceedings of the 9th International Conference on Prostaglandins and Related Compounds;1994b June 6-10;Florence. Milan: Giovanni Lorenzini Medical Foundation, 1994
126. Silver RM, Edwin SS, Trautman MS et al. Bacterial lipopolysaccharide-mediated fetal death: production of a newly recognized form of inducible cyclooxygenase (COX-2) in murine decidua in response to lipopolysaccharide. J Clin Invest 1995;95:725-31
127. Sircar J. Prostaglandin G/H synthase isozymes: a new target for drug discovery. Curr Opin Invest Drugs 1993;2:403-7
128. Sirois J, Richards JS. Purification and characterization of a novel, distinct isoform of prostaglandin endoperoxide synthase induced by human chorionic gonadotropin in granulosa cells of rat preovulatory follicles. J Biol Chem 1992;267:6383-8
129. Sirois J, Simmons DL, Richards JS. Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles. J Biol Chem 1992;267:11586-92
130. Sirois J, Richards, JS. Transcriptional regulation of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. J Biol Chem 1993;268:21931-8
131. Sirois J, Levy LO, Simmons DL, Richards JS. Characterization and hormonal regulation of the promoter of the rat prostaglandin endoperoxide synthase 2 gene in granulosa cells. J Biol Chem 1993;268:7384-5
132. Slater D, Berger L, Newton R, Moore G, Bennett P. The relative abundance of type 1 to type 2 cyclo-oxygenase mRNA in human amnion at term. Biochem Biophys Res Commun 1994;198:304-8
133. Slater D, Berger L, Newton R, Moore G, Bennett P. Expression of cyclooxygenase types 1 and 2 in human fetal membranes at term. Am J Obstet Gynecol 1995;172:77-82
134. Smith WL, Wilkin GP. Immunochemistry of prostaglandin endoperoxide-forming cyclooxygenases: the detection of cyclooxygenases in rat, rabbit and guinea pig kidneys by immunofluorescence. Prostaglandins 1977;13:873-92
135. Smith WL, Bell TG. Immunochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex. Am J Physiol 1978;235: F451-F457
136. Smith WL, Marnett LJ. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim Biophys Acta 1991; 1083:1-17
137. Smith WL, DeWitt DL. Differential interaction of prostaglandin endoperoxide synthases with nonsteroidal anti-inflammatory drugs. Current Opin Invest Drugs 1994;3:1-11
138. 1 within the hypothalamus of the rat. J Physiol (London) 1991;432:99-110
139. Stokes JB. Integrated actions of renal medullary prostaglandins in the control of water excretion. Am J Physiol 1981;240: F471-F480
140. Suh O, Mettlin C, Petrelli NJ. Aspirin use, cancer, and polyps of the large bowel. Cancer 1993;72:1171-7
141. Swierkosz TA, Mitchell JA, Warner TD, Botting RM, Vane JR. Co-induction of nitric oxide synthase and cyclo-oxygenase: interaction between nitric oxide and prostanoids. Br J Pharmacol 1995;114:1335-42
142. Szcepanski A, Moatter T, Carley WW, Gerritsen ME. Induction of cyclooxygenase n in human synovial microvessel endothelial cells by interleukin-1. Arthritis Rheum 1994;37:495-503
143. Takahashi Y, Ueda N, Yoshimoto T et al. Immunoaffinity purification and cDNA cloning of human platelet prostaglandin endoperoxide synthase (cyclooxygenase). Biochem Biophys Res Commun 1992;197:494-500
144. Tanaka K, Shimotori T, Makino S, Aikawa Y, Inaba T, Yoshida C, Takano S. Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one. 1st commun.: Antiinflammatory, analgesic and other related properties. Arzneimittelforschung 1992;42:935-44
145. Tanaka K, Kawasaki H, Kurata K, Aikawa Y, Tsukamoto Y, Inaba T. T-614, a novel antirheumatic drug, inhibits both the activity and induction of cyclooxygenase-2 (COX-2) in cultured fibroblasts. Jpn J Pharmacol 1995;67:305-14
146. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci USA 1994;91:12168-72
147. Thun MJ, Namboodiri MM, Heath CWJr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991; 325:1593-6
148. Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CWJr. Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322-7
149. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature (New Biol) 1971; 231:232-5
150. Vane JR. Towards a better aspirin. Nature 1994;367:215-16
151. Vane JR, Mitchell JA, Appleton I et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci USA 1994;91:2046-50
152. Vane JR, Botting RM. New insights into the mode of action of anti-inflammatory drugs. Inflamm Res 1995;44:1-10
153. Wargovich MJ, Chen CD, Harris C, Yang E, Velasco M. Inhibition of aberrant crypt growth by non-steroidal anti-inflammatory agents and differentiation agents in rat colon. Int J Cancer 1995;60:515-9
154. Wiesenberg-Boettcher I, Schweizer A, Green JR, Mueller K, Maerki F, Pfeilschifter J. The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compound. Drugs Exptl Clin Res 1989;15:501-9
155. Wilborn J, DeWitt DL, Peters-Golden M. Expression and role of cyclooxygenase isoforms in alveolar and peritoneal macrophages. Am J Physiol 1995a;268: L294-L301
156. 2 and to express cyclooxygenase-2. J Clin Invest 1995b;95:1861-8
157. Wong WYL, DeWitt DL, Smith WL, Richards JS. Rapid induction of prostaglandin endoperoxide synthase induced by luteinizing hormone and cAMP is blocked by inhibitors of transcription and translation. Mol Endocrinol 1989; 3:1714-23
158. Wong WYL, Richards JS. Evidence for two antigenically distinct molecular weight variants of prostaglandin H synthase in the rat ovary. Mol Endocrinol 1991;5:1269-79
159. Wong S, Lee SJ, Frierson MR et al. Antiarthritic profile of BF-389- A novel anti-inflammatory agent with low ulcerogenic liability. Agents Actions 1992;37:90-8
160. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991;88:1692-6
161. Xie W, Robertson DL, Simmons DL. Mitogen-inducible prostaglandin G/H synthase: a new target for nonsteroidal anti-inflammatory drugs. Drug Dev Res 1992;25:249-65
162. Xie W, Merrill JR, Bradshaw WS, Simmons DL. Structural determination and promoter analysis of the chicken mitogen-inducible prostaglandin G/H synthase gene and genetic mapping of the murine homologue. Arch Biochem Biophys 1993;300:247-52
163. Yamagata K, Andreasson KI, Kaufmann WE, Barnes CA, Worley PF. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993;11:371-86
164. Yokoyama C, Takai T, Tanabe T. Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence. FEBS Lett 1988;231:347-51
165. Yokoyama C, Tanabe T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun 1989; 165:888-94